Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Marra

Showing results (11-20 of 264) with videos related to

Pageof 27
Sort By:
Journal of Hepatology|September 24, 2016
The inflammasome in liver diseaseAlexander Wree, Fabio Marra
Recenti Progressi in Medicina|February 20, 2002
[Thiazolidinediones and PPARgamma system in repair of liver damage]Fabio Marra, Sabrina Pastacaldi
Pathophysiology : the Official Journal of the International Society for Pathophysiology|July 8, 2008
The role of adipokines in liver fibrosisCristiana Bertolani, Fabio Marra
Hepatology (Baltimore, Md.)|July 9, 2009
Adipokines in liver diseasesFabio Marra, Cristiana Bertolani
Current Pharmaceutical Design|February 12, 2013
Pathophysiology of NASH: perspectives for a targeted treatmentFabio Marra, Sophie Lotersztajn
Antioxidants & Redox Signaling|January 4, 2011
Adipokines and redox signaling: impact on fatty liver diseaseMaurizio Parola, Fabio Marra
Journal of Hepatology|January 27, 2016
Reply to 'Genetic and clinical data reinforce the role of GAS6 and TAM receptors in liver fibrosis'Salvatore Petta, Fabio Marra
Annals of Hepatology|February 22, 2014
SALLuting a new biomarker in hepatocellular carcinomaAndrea L Inghilesi, Fabio Marra
Journal of Hepatology|April 17, 2010
Fibrogenic signalling in hepatic stellate cellsDerek A Mann, Fabio Marra
Journal of Hepatology|November 21, 2017
Lipotoxicity and the gut-liver axis in NASH pathogenesisFabio Marra, Gianluca Svegliati-Baroni
Pageof 27

Showing results (11-20 of 264) with videos related to

Sort By:
Pageof 27
Journal of Hepatology|September 24, 2016
The inflammasome in liver diseaseAlexander Wree, Fabio Marra
Recenti Progressi in Medicina|February 20, 2002
[Thiazolidinediones and PPARgamma system in repair of liver damage]Fabio Marra, Sabrina Pastacaldi
Pathophysiology : the Official Journal of the International Society for Pathophysiology|July 8, 2008
The role of adipokines in liver fibrosisCristiana Bertolani, Fabio Marra
Hepatology (Baltimore, Md.)|July 9, 2009
Adipokines in liver diseasesFabio Marra, Cristiana Bertolani
Current Pharmaceutical Design|February 12, 2013
Pathophysiology of NASH: perspectives for a targeted treatmentFabio Marra, Sophie Lotersztajn
Antioxidants & Redox Signaling|January 4, 2011
Adipokines and redox signaling: impact on fatty liver diseaseMaurizio Parola, Fabio Marra
Journal of Hepatology|January 27, 2016
Reply to 'Genetic and clinical data reinforce the role of GAS6 and TAM receptors in liver fibrosis'Salvatore Petta, Fabio Marra
Annals of Hepatology|February 22, 2014
SALLuting a new biomarker in hepatocellular carcinomaAndrea L Inghilesi, Fabio Marra
Journal of Hepatology|April 17, 2010
Fibrogenic signalling in hepatic stellate cellsDerek A Mann, Fabio Marra
Journal of Hepatology|November 21, 2017
Lipotoxicity and the gut-liver axis in NASH pathogenesisFabio Marra, Gianluca Svegliati-Baroni
Pageof 27